{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:33:40Z","timestamp":1787772820731,"version":"build-2784847793"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Optic neuritis (ON) refers to conditions that involve inflammation of the optic nerve. Various autoantibodies have been found, which are associated with central nervous system inflammatory disorders and have provided much information about the immune targets and mechanisms that impact the prognosis, treatment, and recurrence of atypical ON. Therefore, neurologists and ophthalmologists together should work to find out clinical, laboratory, and imaging findings that may provide important clues to the etiology of atypical ON and its management. Various biomarkers have been identified to confirm and distinguish atypical optic neuritis from others. The purpose of this review is to present the current scenario of atypical ON and its clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_451_20","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T08:27:00Z","timestamp":1608020820000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Atypical optic neuritis"],"prefix":"10.4103","volume":"69","author":[{"given":"Prathama","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mehtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H C","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag Maroti","family":"Tembhurde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0b013e31816f27fe","article-title":"Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations","volume":"14","author":"Abou Zeid","year":"2008","journal-title":"Neurologist"},{"key":"R3-8-20240828","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-8-20240828","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"R5-8-20240828","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/eye.2001.157","article-title":"Optic neuritis in an urban black African community","volume":"15","author":"Pokroy","year":"2001","journal-title":"Eye (Lond"},{"key":"R6-8-20240828","first-page":"195","article-title":"Profile of optic neuritis in Chandigarh and surrounding areas","volume":"28","author":"Jain","year":"1981","journal-title":"Indian J Ophthalmol"},{"key":"R7-8-20240828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0301-4738.121131","article-title":"Clinical profile and short-term outcomes of optic neuritis patients in India","volume":"62","author":"Saxena","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R8-8-20240828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0028-3886.103186","article-title":"Optic neuritis: Experience from a south Indian demyelinating dase registry","volume":"60","author":"Pandit","year":"2012","journal-title":"Neurol India"},{"key":"R9-8-20240828","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","article-title":"Neuroretinitis: Review of the literature and new observations","volume":"31","author":"Purvin","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R10-8-20240828","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archopht.1985.01050080072023","article-title":"Optic nerve involvement in the acute retinal necrosis syndrome","volume":"103","author":"Sergott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R11-8-20240828","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0161-6420(94)31142-0","article-title":"The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS","volume":"101","author":"Engstrom","year":"1994","journal-title":"Ophthalmology"},{"key":"R12-8-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00055735-199706000-00010","article-title":"Cytomegalovirus optic neuritis","volume":"8","author":"Mansour","year":"1997","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-8-20240828","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archpedi.1985.02140130062031","article-title":"Cat-scratch disease. An overview based on a study of 1,200 patients","volume":"139","author":"Carithers","year":"1985","journal-title":"Am J Dis Child"},{"key":"R15-8-20240828","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R16-8-20240828","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"R17-8-20240828","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"R18-8-20240828","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: Clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"R19-8-20240828","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis optica spectrum disorder and anti-MOG syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"key":"R20-8-20240828","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R21-8-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R22-8-20240828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","article-title":"Histopathology and clinical course of MOG-antibody-associated encephalomyelitis","volume":"2","author":"Spadaro","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"R23-8-20240828","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"R24-8-20240828","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","article-title":"MOG antibody-related disorders: Common features and uncommon presentations","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J Neurol"},{"key":"R25-8-20240828","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1167\/iovs.03-1213","article-title":"Subclinical visual involvement in multiple sclerosis: A study by MRI, VEPs, frequency- doubling perimetry, standard perimetry, and contrast sensitivity","volume":"46","author":"Sisto","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-8-20240828","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1352458512447597","article-title":"Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica","volume":"19","author":"Neto","year":"2013","journal-title":"Mult Scler"},{"key":"R27-8-20240828","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jnnp.45.4.303","article-title":"Evoked potentials in the diagnosis of multiple sclerosis: A follow up study","volume":"45","author":"Matthews","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-8-20240828","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21474","article-title":"Axonal loss and myelin in early ON loss in postacute optic neuritis","volume":"64","author":"Klistorner","year":"2008","journal-title":"Ann Neurol"},{"key":"R29-8-20240828","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1177\/1352458514523498","article-title":"Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis","volume":"20","author":"Narayanan","year":"2014","journal-title":"Mult Scler"},{"key":"R30-8-20240828","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNO.0000000000000704","article-title":"Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis","volume":"38","author":"Leocani","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"R31-8-20240828","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"R32-8-20240828","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/1352458514524293","article-title":"Optical coherence tomography and visual evoked potentials: Which is more sensitive in multiple sclerosis?","volume":"20","author":"Di Maggio","year":"2014","journal-title":"Mult Scler"},{"key":"R33-8-20240828","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1167\/iovs.14-14571","article-title":"Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions","volume":"55","author":"Alshowaeir","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-8-20240828","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-8-20240828","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"R36-8-20240828","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","article-title":"Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis","volume":"135","author":"Syc","year":"2012","journal-title":"Brain"},{"key":"R37-8-20240828","first-page":"1002","article-title":"An epidemiological study of neuromyelitis optica in Cuba J Neurol 2009;256:1891-8 Green AJ, Cree BA Distinctive retinal nerve fiber layer and vascular changes in neuromyelitis optica","volume":"80","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R38-8-20240828","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R39-8-20240828","doi-asserted-by":"crossref","first-page":"4015075","DOI":"10.1155\/2019\/4015075","article-title":"Different characteristics of aquaporin-4 and myelin oligodendrocyte glycoprotein antibody-seropositive male optic neuritis in China?","volume":"2019","author":"Song","year":"2019","journal-title":"J Ophthalmol"},{"key":"R40-8-20240828","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ene.13553","article-title":"Clinical usefulness of prognostic biomarkers in optic neuritis","volume":"25","author":"Tejeda-Velarde","year":"2018","journal-title":"Eur J Neurol"},{"key":"R41-8-20240828","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1177\/1352458515574148","article-title":"Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis","volume":"21","author":"Modvig","year":"2015","journal-title":"Mult Scler"},{"key":"R42-8-20240828","doi-asserted-by":"crossref","first-page":"e0146270","DOI":"10.1371\/journal.pone.0146270","article-title":"Change of Th17 Lymphocytes and Treg\/Th17 in Typical and Atypical Optic Neuritis","volume":"11","author":"Cong","year":"2016","journal-title":"PLoS One"},{"key":"R43-8-20240828","first-page":"869","article-title":"Alteration of T helper cell subsets in the optic nerve of experimental autoimmune encephalomyelitis","volume":"25","author":"Tian","year":"2010","journal-title":"Int J Mol Med"},{"key":"R44-8-20240828","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"R45-8-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Control Clin Trials"},{"key":"R46-8-20240828","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(61)91030-3","article-title":"Multiple sclerosis Treatment of acute exacerbations with corticotrophin (ACTH)","volume":"2","author":"Miller","year":"1961","journal-title":"Lancet"},{"key":"R47-8-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"; Neuromyelitis Optica Study Group (NEMOS).Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"key":"R48-8-20240828","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","article-title":"Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin","volume":"15","author":"Tselis","year":"2008","journal-title":"Eur J Neurol"},{"key":"R49-8-20240828","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","article-title":"A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis","volume":"56","author":"Noseworthy","year":"2001","journal-title":"Neurology"},{"key":"R50-8-20240828","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/aian.AIAN_499_16","article-title":"Rituximab in neuromyelitis optica spectrum disorders: Our experience","volume":"20","author":"Jade","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"R51-8-20240828","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/ijms17101666","article-title":"Disease activity and conversion into multiple sclerosis after optic neuritis is treated with erythropoietin","volume":"17","author":"S\u00fchs","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R52-8-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","article-title":"Phenytoin for neuroprotection in patients with acute optic neuritis: A randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Raftopoulos","year":"2016","journal-title":"Lancet Neurol"},{"key":"R53-8-20240828","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acn3.620","article-title":"Predictors of response to opicinumab in acute optic neuritis","volume":"5","author":"Cadavid","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"R54-8-20240828","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/WNO.0000000000000760","article-title":"Effects of varying intranasal treatment regimens in ST266-mediated retinal ganglion cell neuroprotection","volume":"39","author":"Khan","year":"2019","journal-title":"J Neuroophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_451_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:13:39Z","timestamp":1787771619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_451_20"}},"subtitle":["An overview"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_451_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}